Healthcare -
Biotechnology - NASDAQ - US
$ 1.135
-12 %
$ 4.72 M
Market Cap
-0.09
P/E
MBRX - CASH & EQUIVALENTS
Cash & Equivalents MBRX - Moleculin Biotech, Inc.
23.6 M
LAST VALUE
-42.37%
2 YEAR CAGR
26.98%
5 YEAR CAGR
0.00%
10 YEAR CAGR